Pyruvate Kinase M2 Is a Poor Prognostic Marker of and a Therapeutic Target in Ovarian Cancer

PLoS ONE- United States

doi 10.1371/journal.pone.0182166

Full Text

Abstract

Available in

Date

Authors

Publisher

Public Library of Science (PLoS)

Related search

BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer

PLoS ONE
Multidisciplinary
2013English

Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2015English

Calnexin, an ER-induced Protein, Is a Prognostic Marker and Potential Therapeutic Target in Colorectal Cancer

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Pyruvate Kinase M2 and Lactate Dehydrogenase a Are Overexpressed in Pancreatic Cancer and Correlate With Poor Outcome

PLoS ONE
Multidisciplinary
2016English

Tetraspanin CD151 Is a Novel Prognostic Marker in Poor Outcome Endometrial Cancer

British Journal of Cancer
Cancer ResearchOncology
2011English

Serine Is a Natural Ligand and Allosteric Activator of Pyruvate Kinase M2

Nature
Multidisciplinary
2012English

Minichromosome Maintenance Protein 7 Is a Potential Therapeutic Target in Human Cancer and a Novel Prognostic Marker of Non-Small Cell Lung Cancer

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2011English

CD24 Is Expressed in Ovarian Cancer and Is a New Independent Prognostic Marker of Patient Survival

American Journal of Pathology
Forensic MedicinePathology
2002English

Upregulated Expression of Pyruvate Kinase M2 mRNA Predicts Poor Prognosis in Lung Adenocarcinoma

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy